Flat Medical Expands Adoption of EpiFaith Smart Syringe Among U.S. Hospitals

Flat Medical Expands Adoption of EpiFaith® Smart Syringe Among U.S. Hospitals

In a groundbreaking development for the medical field, Flat Medical has announced that more than 30 hospitals and pain management centers across the United States have started utilizing the EpiFaith® Smart Syringe in their routine clinical practices. This innovative tool, designed for precision needle access, is particularly focused on anesthesia, critical care, and pain management.

The EpiFaith Smart Syringe, which is both FDA 510(k)-cleared and CE-marked, is a game-changer in epidural procedures. It provides real-time visual pressure feedback during the loss-of-resistance technique, offering clinicians an objective measure when identifying the epidural space.

A Milestone in Medical Adoption

Mark Rabe, Vice President of North America for Flat Medical, emphasized the importance of this milestone, stating, "Surpassing 30 hospitals and pain centers is significant, but we see it as just the beginning. It is encouraging to see institutions integrating the EpiFaith Smart Syringe into their practices as they aim to elevate the standard of epidural care. Numerous major integrated delivery networks are laying the groundwork for a system-wide conversion, essentially marking a transition from early adoption to establishing a new standard in epidural access."

Clinical Perspectives on EpiFaith

Prominent clinicians are expressing their satisfaction with the device. Dr. Jay Kersh, an obstetric anesthesiologist from the Greater Chicago area, highlights the advantages of the EpiFaith Smart Syringe. "It delivers real-time visual feedback during the loss of resistance, providing our anesthesia team with an additional objective indicator for identifying the epidural space. Particularly in labor and delivery units, where patient anatomy can complicate placement, this added feedback proves invaluable. EpiFaith offers a novel, arguably superior technique for epidural catheter placement, boosting confidence during these critical procedures."

Adding to this, Dr. Vafi Salmasi, an interventional pain physician in the San Francisco Bay Area, shared, "The EpiFaith Smart Syringe has transformed my interventional pain practice. It not only provides real-time visual feedback that enhances my confidence during epidural procedures, but it also integrates seamlessly into my existing practices. It's an intuitive tool that aids in achieving consistent and efficient epidural access for my patients."

Technical Overview of the EpiFaith Smart Syringe

The underlying technology of the EpiFaith Smart Syringe relies on pressure visualization, enabling clinicians to receive immediate feedback during the loss-of-resistance technique — a critical aspect of identifying the epidural space. The device's design contributes to its effectiveness, receiving significant praise from users for its simplicity and efficacy.

About Flat Medical

Flat Medical is dedicated to advancing precision needle access and guidance solutions in medical fields like anesthesia, critical care, and pain management. Their products focus on providing objective, real-time feedback to clinicians during needle-based procedures, aiming to standardize and enhance the reliability of these vital access points. Notably, the EpiFaith Smart Syringe represents just one component of Flat Medical's innovation strategy; the company is also developing the InjeQ® platform, a bioimpedance-based smart needle that has received FDA Breakthrough Device Designation.

For further information about Flat Medical and their products, visit Flat Medical's Official Website.

Conclusion

The adoption of the EpiFaith Smart Syringe across various healthcare institutions not only signifies a major step forward in epidural procedure technology but also demonstrates a broader commitment within the medical community to enhance patient safety and procedural outcomes. As more hospitals embrace this innovative approach, the potential for improved care in anesthesia practices becomes increasingly evident.